RE:Corporate Update Although management lost precious time (and our money) and needed a “pandemic in an unrelated disease to get them to look across the campus” (as previously mentioned by M101), this update presents a coherent strategy, complementing the company’s original focus, with elements (previously communicated) that might (if successful) set PMN in the spot light before the end of the year.
On the negative side, it is clear that management constantly failed to meet his own deadlines (including the so-called perpetual “near-term catalyst”, which never materialized) and, consequently, I remain extremely cautious about the planning presented on page 4 (except for the Covid).
In short, I would have been on the buy side but, since management demonstrated a lack of transparency (if not a lack of respect to the shareholders) as regards to the cash (if any) obtained with the “repriced warrants”, I suspect that a PP is under preparation. Therefore, in the absence of such transparency, I remain on the side line…
GLTA